Olmitel-Trio 40mg/10mg/12.5mg Tablet

Overview Olmitel-Trio 40mg/10mg/12.5mg Tablet

Hyperten-Trio (40mg/10mg/12.5mg) tablets combine medications to effectively manage hypertension when monotherapy proves insufficient. This triple-action formulation lowers elevated blood pressure, significantly reducing the risk of stroke and myocardial infarction. Administer Hyperten-Trio with food, at the same time daily, following your doctor's prescribed dosage. Continuous use is crucial; discontinue only as directed. The diuretic component increases urination; avoid doses within four hours of bedtime. Consistent use, even during symptom-free periods, is key to maximizing therapeutic benefits. Untreated hypertension is often asymptomatic; cessation increases cardiovascular event risk. Common side effects include edema, cephalgia, vertigo, fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your physician. Maintain adequate hydration to mitigate potential side effects like myalgia, xerostomia, and polydipsia. Prior to commencing therapy, inform your doctor of any renal or hepatic impairment, pregnancy, breastfeeding, or concurrent medications, particularly cardiovascular or antihypertensive agents. Regular monitoring of blood pressure, renal function, electrolyte levels, and glycemia is essential to optimize treatment efficacy and safety.

Primary Ingredients of Olmitel-Trio 40mg/10mg/12.5mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Olmitel-Trio 40mg/10mg/12.5mg Tablet

Elevated arterial blood pressure

Major Benefits of Olmitel-Trio 40mg/10mg/12.5mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Olmitel-Trio 40mg/10mg/12.5mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Olmitel-Trio 40mg/10mg/12.5mg Tablet:

• Ankle swelling
• Headache
• Dizziness
• Tiredness
• Palpitations
• Sleepiness
• Increased blood uric acid
• Glucose intolerance
• Taste change
• Flushing (sense of warmth in the face, ears, neck and trunk)
• Upset stomach
• Altered blood lipid level

How to use Olmitel-Trio 40mg/10mg/12.5mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Olmitel-Trio 40mg/10mg/12.5mg tablet should be administered with a meal.

How Olmitel-Trio 40mg/10mg/12.5mg Tablet works:

Olmitel-Trio tablets (40mg/10mg/12.5mg) contain olmesartan medoxomil, cilnidipine, and chlorthalidone. Olmesartan medoxomil, an angiotensin II receptor antagonist, and cilnidipine, a calcium channel blocker, act synergistically to dilate blood vessels, reducing blood pressure. Chlorthalidone, a diuretic, facilitates fluid and electrolyte excretion, contributing to lowered blood pressure and improved circulation via vasodilation.

What if you forget to take Olmitel-Trio 40mg/10mg/12.5mg Tablet :

Should you forget a dose of Olmitel-Trio 40mg/10mg/12.5mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.